ArticleMolecular therapy oncolytics2021

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus.

Takuma Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.